PubTransformer

A site to transform Pubmed publications into these bibliographic reference formats: ADS, BibTeX, EndNote, ISI used by the Web of Knowledge, RIS, MEDLINE, Microsoft's Word 2007 XML.




PMID- 28564565
OWN - NLM
STAT- MEDLINE
DA  - 20170531
DCOM- 20170620
LR  - 20170620
IS  - 1533-4406 (Electronic)
IS  - 0028-4793 (Linking)
VI  - 376
IP  - 22
DP  - 2017 Jun 01
TI  - Myeloproliferative Neoplasms.
PG  - 2168-2181
LID - 10.1056/NEJMra1406186 [doi]
FAU - Spivak, Jerry L
AU  - Spivak JL
AD  - From the Hematology Division, Department of Medicine, Johns Hopkins University
      School of Medicine, Baltimore.
LA  - eng
PT  - Journal Article
PT  - Review
PL  - United States
TA  - N Engl J Med
JT  - The New England journal of medicine
JID - 0255562
RN  - 0 (Antineoplastic Agents)
SB  - AIM
SB  - IM
MH  - Age Factors
MH  - Antineoplastic Agents/therapeutic use
MH  - Bone Marrow Transplantation
MH  - Female
MH  - Gene Expression
MH  - Hematopoietic Stem Cells
MH  - Humans
MH  - Leukemia, Myeloid, Acute/etiology
MH  - Male
MH  - *Mutation
MH  - Myeloproliferative Disorders/complications/diagnosis/*genetics/therapy
MH  - Phenotype
MH  - Polycythemia Vera/genetics/therapy
MH  - Primary Myelofibrosis/genetics/therapy
MH  - Sex Factors
MH  - Thrombocythemia, Essential/genetics/therapy
EDAT- 2017/06/01 06:00
MHDA- 2017/06/21 06:00
CRDT- 2017/06/01 06:00
AID - 10.1056/NEJMra1406186 [doi]
PST - ppublish
SO  - N Engl J Med. 2017 Jun 1;376(22):2168-2181. doi: 10.1056/NEJMra1406186.